Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01517607
Other study ID # 000027
Secondary ID
Status Completed
Phase N/A
First received January 20, 2012
Last updated September 30, 2015
Start date February 2012
Est. completion date December 2013

Study information

Verified date September 2015
Source Ferring Pharmaceuticals
Contact n/a
Is FDA regulated No
Health authority Germany: Federal Institute for Drugs and Medical Devices
Study type Observational

Clinical Trial Summary

This non-interventional study examines whether the patient's level of information and the consideration of the patient's preference have a positive effect on the compliance and thus also on the therapeutic success.


Recruitment information / eligibility

Status Completed
Enrollment 506
Est. completion date December 2013
Est. primary completion date December 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients are treated for the first time with oral PENTASA®, e.g. following first diagnosis of ulcerative colitis for treatment of an acute episode or

- Following a therapy-free period (no previous mesalazine therapy) or due to poor response or underdosage oder lacking acceptance of the previous medication the patients are re-adjusted to oral PENTASA®,

- The patients (= 18 years) have been informed about the NIS and have given their written consent for participation.

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Other:
Mesalazine
Patient's treated with oral Mesalazine

Locations

Country Name City State
Germany Investigational site, Wettinerstraße 22 Altenburg
Germany Investigational site, Marienstraße 6 Amberg
Germany Investigational site, Adam-Ries-Straße 57c Annaberg-Buchholz
Germany Investigational site, Goethestraße 5 Ansbach
Germany Investigational site, Elisenstraße 32 Aschaffenburg
Germany Investigational site, Prinzregentenstraße 8 Augsburg
Germany Investigational site, Koblenzer Straße 37 Bad Godesberg
Germany Investigational site, Goethestraße 15g Bad Neustadt
Germany Investigational site, Töpferstraße 17 Bautzen
Germany Investigational site, Bahnhofstraße 18 Berlin
Germany Investigational site, Blankenburger Chaussee 86 Berlin
Germany Investigational site, Bundesallee 104-105 Berlin
Germany Investigational site, Ehrenfelsstraße 47 Berlin
Germany Investigational site, Etkar-Andre-Straße 8 Berlin
Germany Investigational site, Hohenzollerndamm 47a Berlin
Germany Investigational site, Innsbrucker Straße 58 Berlin
Germany Investigational site, Klosterstraße 34 Berlin
Germany Investigational site, Kurfürstendamm 42 Berlin
Germany Investigational site, Mohrenstraße 6 Berlin
Germany Investigational site, Myslowitzer Straße 49 Berlin
Germany Investigational site, Schönhauser Allee 118 Berlin
Germany Investigational site, Schönhauser Allee 129 Berlin
Germany Investigational site, Schönstraße 90 Berlin
Germany Investigational site, Treskowallee 99 Berlin
Germany Investigational site, Hauptstraße 88 Bielefeld
Germany Investigational site, Hauptstraße 9 Bietigheim-Bissingen
Germany Investigational site, Kasernenstraße 22-24 Bonn
Germany Investigational site, Münsterstraße 18 Bonn
Germany Investigational site, Propst-Sievert-Weg 9 Borken
Germany Investigational site, Trauerberg 27-28 Brandenburg/Havel
Germany Investigational site, Wetzlarer Straße 22 Butzbach
Germany Investigational site, Hermann-Hesse-Platz 3 Calw
Germany Investigational site, Dortmunder Straße Castrop-Rauxl
Germany Investigational site, Hainstraße 112 Chemnitz
Germany Investigational site, Bahnhofstraße 64 Cottbus
Germany Investigational site, Vetschauer Straße 11a Cottbus
Germany Investigational site, Frankfurter Straße 3 Darmstadt
Germany Investigational site, Rheinstraße 44-46 Darmstadt
Germany Investigational site, Lagesche Straße 19 Detmold
Germany Investigational site, Jahnstraße 1 Dingolfing
Germany Investigational site, Karlsbader Straße 7 Dinkelsbühl
Germany Investigational site, Recklinghäuser Straße 14 Dorsten
Germany Investigational site, Rheinlanddamm 10 Dortmund
Germany Investigational site, Lukasstraße 3 Dresden
Germany Investigational site, Rehefelder Straße 12 Dresden
Germany Investigational site, Mühlhäuser Straße 94, Haus F Eisenach
Germany Investigational site, Winkelgasse 1 Ellefeld
Germany Investigational site, Königstraße 12-14 Elmshorn
Germany Investigational site, Märkischestraße 30 Engelskirchen
Germany Investigational site, Franz-Busbach-Straße 8 Erftstadt
Germany Investigational site, Neuwerkstraße 2 Erfurt
Germany Investigational site, Ruhrallee 81 Essen
Germany Investigational site, Viktoriastraße 5 Euskirchen
Germany Investigational site, Im Prüfling 23 Frankfurt
Germany Investigational site, Hochstraße 43 Frankfurt Main
Germany Investigational site, Pfingsweidstraße 4 Frankfurt Main
Germany Investigational site, Stresemannallee 3 Frankfurt Main
Germany Investigational site, Habsburgerstraße 105 Freiburg
Germany Investigational site, Schnetzenhauser Straße 5 Friedrichshafen
Germany Investigational site, Moststraße 19 Fürth
Germany Investigational site, Gartenstraße 29 Gardelegen
Germany Investigational site, Hauptstraße 60-64 Garmisch-Partenkirchen
Germany Investigational site, Am Markt 3 Gehrden
Germany Investigational site, In der Heide 19 Gelsenkirchen
Germany Investigational site, Von-der-Recke-Straße 14 Gelsenkirchen
Germany Investigational site, Pollinger Straße 23 Gilching
Germany Investigational site, Von-Werth-Straße 5 Grevenbroich
Germany Investigational site, Avenwedder Straße 50 Gütersloh
Germany Investigational site, Hachelweg 19 Hachelweg 19
Germany Investigational site, Fürstin-Eugenie-Straße 7 Hachingen
Germany Investigational site, Buscheystraße 15a Hagen
Germany Investigational site, Eppendorfer Baum 35-37 Hamburg
Germany Investigational site, Eppendorfer Landstraße 42 Hamburg
Germany Investigational site, Fontenay 1d Hamburg
Germany Investigational site, Harksheider Straße 3 Hamburg
Germany Investigational site, Schäferkampsallee 56-58 Hamburg
Germany Investigational site, Schlossstrasse 44 Hamburg
Germany Investigational site, Sudetenweg 6 Hamm
Germany Investigational site, Staufenbergstraße 31 Heilbronn
Germany Investigational site, Frankfurter Straße 100a Hennef
Germany Investigational site, Am Ruschenhof 24 Herne
Germany Investigational site, Wiescherstraße 20 Herne
Germany Investigational site, Seestraße 43 Herrsching
Germany Investigational site, Waisenhausstraße 2 Iserlohn
Germany Investigational site, J.-Lange-straße 20 Jerichow
Germany Investigational site, Prinzenallee 10 Jever
Germany Investigational site, Hans-Sachs-Straße 1 Karlsruhe
Germany Investigational site, Am Tiefen Weg 2 Karlstadt
Germany Investigational site, Opernstraße 9 Kassel
Germany Investigational site, Feldstraße 5-7 Kiel
Germany Investigational site, Moltkestraße 9 Kitzingen
Germany Investigational site, Graseggerstraße 105 Köln
Germany Investigational site, Venloer Straße 247 Köln
Germany Investigational site, Herzog-Adolph-Straße 13 Königstein
Germany Investigational site, Schalaunische Straße 6-7 Köthen
Germany Investigational site, Dreifaltigkeitsplatz 177 Landshut
Germany Investigational site, Röntgenstraße 6-8 Langen
Germany Investigational site, Funkenburgstraße 19 Leipzig
Germany Investigational site, Johannisplatz 1 Leipzig
Germany Investigational site, Markt 3 Leisnig
Germany Investigational site, Am Gesundheitspark 11 Leverkusen
Germany Investigational site, Kronsforder Allee 19 Lübeck
Germany Investigational site, Kronsforder Allee 69 Lübeck
Germany Investigational site, Yorckstraße 1 Ludwigshafen
Germany Investigational site, Berliner Straße 8 Lutherstadt Wittenberg
Germany Investigational site, Bismarckplatz 1 Mannheim
Germany Investigational site, Stiftsweg 17 Mechernich
Germany Investigational site, Am Harras 2 München
Germany Investigational site, Irisstraße 23 München
Germany Investigational site, Kaulbachstraße 61 München
Germany Investigational site, Maximilianstraße 16 München
Germany Investigational site, Schönfeldstraße 16 München
Germany Investigational site, Unterer Markt 26-27 Neumarkt
Germany Investigational site, Hofgründchen 13 Neuwied
Germany Investigational site, Am Stadtpark 2 Nürnberg
Germany Investigational site, Glogauer Straße 42 Nürnberg
Germany Investigational site, Weiltinger Straße 11 Nürnberg
Germany Investigational site, Hauptstraße 36 Oldenburg
Germany Investigational site, Neue Donnerschweer Straße 30 Oldenburg
Germany Investigational site, Ofener Straße 30 Oldenburg
Germany Investigational site, Bramscher Straße 242 Osnabrück
Germany Investigational site, Le-Mans-Wall 5 Paderborn
Germany Investigational site, Westendstraße 38 Paderborn
Germany Investigational site, Haptkanal rechts 75 Papenburg
Germany Investigational site, Neundorfer Straße 14 Plauen
Germany Investigational site, Allee nach Sanccouci 7 Potsdam
Germany Investigational site, Großbeerenstraße 301 Potsdam
Germany Investigational site, R.-Breitscheid-Straße 56 Potsdam
Germany Investigational site, Kaiserstraße 166 Radevormwald
Germany Investigational site, Neue Straße 34 Reinsdorf
Germany Investigational site, Keramikerstraße 61 Rheinbach
Germany Investigational site, St.-Petersburger-straße 18c Rostock
Germany Investigational site, Tegernseerstraße 100 Rottach-Weissach
Germany Investigational site, Marktplatz 23 Rottenburg
Germany Investigational site, Waldhausstraße 13 Schmalkalden
Germany Investigational site, Krankenhausstraße 20 Schwalmstadt
Germany Investigational site, Virchowstraße 10c Singen
Germany Investigational site, Wallstraße 38 Stade
Germany Investigational site, Am Wallgraben 99 Stuttgart
Germany Investigational site, Röhre 1 Sundern
Germany Investigational site, Straße des Friedens 34c Teuchern
Germany Investigational site, Hambrocker Straße 53 Uelzen
Germany Investigational site, Andreaestraße 16/1 Vahingen
Germany Investigational site, Hochstraße 20 Waltrop
Germany Investigational site, Kletzstraße 13B Waren
Germany Investigational site, Fischergasse 16 Weilheim
Germany Investigational site, Julius-Leber-Strasße 8 Wesel
Germany Investigational site, Westring 14 Wesseling
Germany Investigational site, Forsthausstraße 1e Wetzlar

Sponsors (2)

Lead Sponsor Collaborator
Ferring Pharmaceuticals Ferring Arzneimittel GmbH

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Patient compliance: Measured by patient response to a questionnaire Month 0 - Month 12 No
Secondary Patient's level of information: Measured by patient response to a questionnaire Month 0 - Month 12 No
Secondary Patient's preference for the oral pharmaceutical form: Measured by patient response to a questionnaire Month 0 - Month 12 No
Secondary Reasons for the therapeutic decision of the physician: Measured by physician responses Month 0 No
Secondary Laboratory parameters of predefined blood measurements Faecal calprotectin (including test used), faecal lactoferrin. Number of leukocytes, C-reactive protein, blood sedimentation rate. Haemoglobin, serum iron, serum ferritin, transferrin saturation (TSAT) Month 0- Month 12 No
Secondary Ulcerative Colitis Disease Activity Index (UCDAI) UCDAI = Blood in stool, stool frequency, overall evaluation of the physician, endoscopic evaluation (optional) Month 0 - Month 12 No
Secondary Adverse drug reactions: measured by number of patients and event severity Month 0 - Month 12 Yes
See also
  Status Clinical Trial Phase
Recruiting NCT05702879 - Combined Microbiota and Metabolic Signature in Ulcerative Colitis Predicts Anti-Inflammatory Therapy Success
Not yet recruiting NCT05953402 - A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring
Recruiting NCT05316584 - A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy N/A
Recruiting NCT03950232 - An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis Phase 3
Completed NCT03124121 - Study of the Golimumab Exposure-Response Relationship Using Serum Trough Levels Phase 4
Not yet recruiting NCT06100289 - A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease Phase 3
Withdrawn NCT04209556 - A Study To Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative Colitis Phase 2
Terminated NCT00061282 - Clotrimazole Enemas for Pouchitis in Children and Adults Phase 1/Phase 2
Recruiting NCT04398550 - SCD vs. Mediterranean Diet Therapy in Ulcerative Colitis N/A
Recruiting NCT04314375 - Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis Phase 4
Active, not recruiting NCT04857112 - Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis Phase 2
Completed NCT05051943 - A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
Active, not recruiting NCT04033445 - A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis Phase 2/Phase 3
Recruiting NCT05428345 - A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea
Active, not recruiting NCT06221995 - Energy Expenditure in Patients With Ulcerative Colitis Undergoing Surgery
Recruiting NCT04767984 - Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis Phase 2
Completed NCT02508012 - Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases N/A
Recruiting NCT06071312 - FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach Phase 1/Phase 2
Completed NCT03760003 - Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis Phase 2
Not yet recruiting NCT05539625 - Mini-MARVEL - Mitochondrial Antioxidant Therapy in Ulcerative Colitis Phase 2